Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.89    -0.25 (-11.68%)
Bid:
1.895
Ask:
2.19
Spread: 0.295 (15.567%)
Market Cap: £37.92m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor Update

24 Aug 2023 12:29

RNS Number : 3724K
Quadrise PLC
24 August 2023
 

24 August 2023

Quadrise Plc ("Quadrise" or the "Company")

Valkor Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its project with Valkor Technologies LLC ('Valkor') in Utah, USA.

A meeting of the State of Utah's Board of Oil, Gas and Mining ('the Board') was held yesterday to review a unitisation plan involving drilling of up to 119 wells to establish the Asphalt Ridge Enhanced Recovery Unit for the in-situ production of heavy oil from sands by Valkor, on behalf of project sponsors Heavy Sweet Oil LLC and AC Oil LLC.

The Board denied the order on the basis that without a producing well in place, there was not yet sufficient evidence of an oil deposit to support the unitisation plan at this time. The decision does not prevent Valkor from drilling the 4 pilot wells already granted by the Board in December 2022. Pilot well drilling will be necessary to support a further application for unitisation in due course.

Quadrise is now working with Valkor to assess and clarify any impact on the conditional site license and supply agreement for Quadrise's emulsion fuel technology announced on 12 June 2023 and a further announcement will be made as soon as practicable.

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay Thomson

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZLFLXVLLBBQ
Date   Source Headline
26th Nov 200912:59 pmBUSDisclosure of Short Position
24th Nov 200911:25 amRNSResult of General Meeting
18th Nov 20095:15 pmRNSHolding(s) in Company
16th Nov 20095:24 pmRNSHolding(s) in Company
10th Nov 20099:49 amRNSHolding(s) in Company
6th Nov 20093:05 pmRNSDirector/PDMR Shareholding
6th Nov 20093:01 pmRNSHolding(s) in Company
6th Nov 20092:20 pmBUSDisclosure of Short Position
5th Nov 200912:56 pmRNSPublication of Prospectus
5th Nov 20097:00 amRNSRights Issue
5th Nov 20097:00 amRNSHalf Yearly Results
4th Nov 20096:28 pmRNSHolding(s) in Company
3rd Nov 20095:48 pmRNSHolding(s) in Company
2nd Nov 20097:00 amRNSStatement re. Press Comment
13th Oct 20092:55 pmRNSDirector/PDMR Shareholding
12th Oct 20092:18 pmRNSHolding(s) in Company
9th Oct 20097:00 amRNSDisposal
1st Oct 20097:00 amRNSTrading Statement
30th Sep 200911:08 amRNSTotal Voting Rights
29th Sep 20091:20 pmRNSHolding(s) in Company
16th Sep 20092:18 pmRNSDirector/PDMR Shareholding
15th Sep 200910:12 amRNSHolding(s) in Company
11th Sep 20094:57 pmRNSHolding(s) in Company
11th Sep 20093:56 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSDisposal
9th Sep 20093:30 pmRNSResult of AGM
9th Sep 20099:45 amRNSDirectorate Change
2nd Sep 200912:42 pmRNSHolding(s) in Company
1st Sep 20093:31 pmRNSHolding(s) in Company
1st Sep 200912:01 pmRNSHolding(s) in Company
26th Aug 20093:48 pmRNSHolding(s) in Company
24th Aug 20095:09 pmRNSHolding(s) in Company
21st Aug 20093:37 pmRNSHolding(s) in Company
19th Aug 200911:52 amRNSDirector/PDMR Shareholding
18th Aug 200911:04 amRNSDirector/PDMR Shareholding
14th Aug 200911:00 amRNSAnnual Information Update
14th Aug 20099:43 amRNSHolding(s) in Company
13th Aug 20099:37 amRNSDirector/PDMR Shareholding
11th Aug 20099:14 amRNSDirector/PDMR Shareholding
7th Aug 200912:10 pmRNSDirector/PDMR Shareholding
31st Jul 200912:51 pmRNSTotal Voting Rights
29th Jul 20097:00 amRNSInterim Management Statement
28th Jul 20093:18 pmRNSNotice of IMS
16th Jul 20092:33 pmRNSDirector/PDMR Shareholding
16th Jul 200912:19 pmRNSDirector Declaration
15th Jul 20097:00 amRNSDirector/PDMR Shareholding
13th Jul 20092:45 pmRNSAnnual Financial Report
7th Jul 20092:20 pmRNSHolding(s) in Company
25th Jun 20095:17 pmRNSNotification of major interest in shares
22nd Jun 200912:54 pmRNSInterests of Directors and PDMRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.